Q Chu Selected Research

C-Reactive Protein

1/2020

Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Q Chu Research Topics

Disease

3	Neoplasms (Cancer) 04/2018 - 05/2001
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 11/2015
2	Peritoneal Neoplasms 05/2014 - 01/2007
2	Infections 12/2010 - 03/2001
2	Osteoarthritis 08/2004 - 01/2001
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Cough 01/2020
1	Fever (Fevers) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Pneumonia (Pneumonitis) 04/2018
1	Colorectal Neoplasms (Colorectal Cancer) 05/2014
1	Citrullinemia 11/2011
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2011
1	Joint Instability (Joint Laxity) 08/2002
1	Rupture 08/2002
1	type 2 alpha 1 Collagenopathy 08/2002
1	Human Influenza (Influenza) 12/2001
1	Diabetes Mellitus 06/2001
1	Insulin Resistance 06/2001
1	Hepatocellular Carcinoma (Hepatoma) 05/2001
1	Knee Osteoarthritis 11/2000

Drug/Important Bio-Agent (IBA)

3	EpitopesIBA 08/2002 - 11/2000
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2020
1	melanopsinIBA 01/2022
1	OF 900IBA 01/2022
1	trastuzumab deruxtecanIBA 01/2022
1	disitamab vedotinIBA 01/2022
1	MelatoninIBA 01/2022
1	osimertinibIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 04/2018
1	VaccinesIBA 11/2015
1	belagenpumatucel LIBA 11/2015
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 05/2014
1	Uridine Monophosphate (UMP)IBA 11/2011
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 12/2010
1	Proteoglycans (Proteoglycan)IBA 08/2002
1	Collagen Type II (Type II Collagen)IBA 08/2002
1	salicylhydroxamic acid (SHAM)IBA 08/2002
1	Collagenases (Collagenase)FDA Link 08/2002
1	PowdersIBA 12/2001
1	AntigensIBA 12/2001
1	Proteins (Proteins, Gene)FDA Link 12/2001
1	Protein Kinases (Protein Kinase)IBA 06/2001
1	Liposomes (Liposome)IBA 05/2001
1	Egtazic Acid (EGTA)IBA 03/2001
1	ManganeseIBA 01/2001
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2001
1	Glucosamine (Dona)IBA 01/2001
1	GlycosaminoglycansIBA 11/2000
1	ChondroitinIBA 11/2000

Therapy/Procedure

3	Therapeutics 01/2020 - 11/2015
2	Drug Therapy (Chemotherapy) 04/2018 - 11/2015
2	Hyperthermic Intraperitoneal Chemotherapy 05/2014 - 01/2007
2	Cytoreduction Surgical Procedures 05/2014 - 01/2007
1	Meniscectomy 08/2004
1	Intravenous Administration 05/2001